secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2025-10-28T23:59:59+00:00
Accession:  0001425450-25-000111
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q3 revenue $61.2M (+12% YoY); adjusted EBITDA up 56% to $6.2M; raises FY2025 revenue guidance
--------------------------------------------------------------------------------

- Revenue $61.2M, +12% YoY (17% ex-7D capital); Trauma & Deformity +17%, Scoliosis +4%.
- GAAP EPS -$0.50 vs -$0.34; non-GAAP EPS -$0.24 vs -$0.18; net loss $11.8M vs $7.9M.
- Adjusted EBITDA $6.2M (+56% YoY); free cash flow usage improved to $3.4M from $11.6M.
- FY2025 revenue guidance raised to $233.5-234.5M (+14-15%); adjusted EBITDA guidance reiterated $15-17M.
- Recorded $2.3M restructuring charge and $2.3M intangible impairment (ApiFix, Telos, Medtech).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000111/0001425450-25-000111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000111/kids-20251028.htm
  HTML page:      https://secwatch.observer/filing/0001425450-25-000111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer